ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.

Hye Soon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.